<DOC>
	<DOCNO>NCT01982604</DOCNO>
	<brief_summary>A Phase 1 , open-label randomize crossover trial Healthy Volunteers evaluate PK/PD TI ( Technosphere® Insulin ) prepare insulin two different supplier .</brief_summary>
	<brief_title>Comparison 30 Units TI ( Technosphere® Insulin ) Prepared With Insulin From Two Different Suppliers</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Men woman age 18 55 year , consider healthy base screen physical examination , medical history , clinical chemistry , urinalysis HNVs screen blood pressure le 140/90 mm Hg Subjects hypertension control 1 medication blood pressure le 140/90 mm Hg Note : For subject blood pressure 140/90 mm Hg ; two additional reading 5 minute apart allow last blood pressure reading must range Subjects hypercholesterolemia control 1 medication lowdensity lipoprotein value le 160 mg/dL Good venous access blood draw No smoking past 6 month ( include cigarette , cigar , pipe ) urine cotinine test &lt; 100 ng/mL Body mass index ( BMI ) &lt; 32 kg/m2 Completion inform consent form Blood donation ( 500 mL ) within last 8 week Fasting blood sugar &gt; 100 mg/dL History coronary artery disease , peripheral vascular disease , congestive heart failure Allergy study drug , component Boost Boost Plus , study material Clinically significant active chronic illness History asthma , COPD , clinically relevant chronic lung disease Respiratory tract infection within 4 week screen History drug alcohol abuse within past 5 year Positive urine drug screen Clinically significant screening ECG , physical examination , laboratory test , vital sign abnormality Exposure investigational drug device within 30 day treatment within 90 day treatment drug know modify glucose metabolism History malignancy within 5 year screen ( basal cell carcinoma ) History human immunodeficiency virus ( HIV ) infection hepatitis B C Women pregnant , lactating , plan become pregnant clinical study period Women childbearing potential ( premenopausal undergone hysterectomy bilateral tubal ligation , postmenopausal few 2 year ) practice adequate birth control . Adequate birth control define use oral , percutaneous , transdermal contraceptive ; condom diaphragms ( double barrier ) spermicide ; intrauterine device . Postmenopausal purpose clinical study include experience amenorrhea 2 year surgically sterile . Any subject , opinion PI designee , appear qualified study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>